Insulin Delivery Devices Market to Reach $33.3 Billion by 2035

Insulin Delivery Devices market was valued at $16.2 billion in 2025 and is expected to reach $33.3 billion by 2035, registering a CAGR of 7.5% during the forecast period from 2026 to 2035. The global insulin delivery devices market is expanding as the number of people living with diabetes rises sharply around the world, increasing demand for effective insulin administration tools such as pens, syringes, jet injectors, and pumps. Higher prevalence fosters greater clinical diagnosis and intensifies the need for ongoing glycemic management, directly supporting broader adoption of advanced delivery systems. Improved access to healthcare facilities and greater patient awareness of self?management options are amplifying device uptake across both hospital and home care environments. Manufacturers are responding with innovations that improve convenience, accuracy, and integration with digital health systems, which reinforces market relevance. As a result, sustained growth in the diabetic population is a central driver underpinning market expansion.

Browse the full report description of “Insulin Delivery Devices Market Size, Share & Trends Analysis Report by Type (Insulin Syringes, Insulin Pens, Insulin Jet Injectors, and Insulin Pumps), and by End-User (Hospitals & Clinics, and Homecare), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/insulin-delivery-devices-market

• International Diabetes Federation (IDF) estimates that 589 million adults (20–79 years) globally were living with diabetes in 2024, representing 1% of the global adult population.
• IDF projects a rise to approximately 853 million adults with diabetes by 2050.
• IDF data indicates that over 4 in 10 adults with diabetes are not yet diagnosed, suggesting further potential growth in demand for insulin delivery solutions as diagnoses improve.
• Adults aged 65 and older show the highest prevalence, underscoring increasing demand among aging populations.
• The majority of diabetes cases are type 2, which often progresses to insulin dependency, reinforcing sustained device requirement.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Type
  • End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – Abbott Laboratories, Becton, Dickinson and Company, Eli Lilly and Company, Medtronic Plc, Sanofi, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Insulin Delivery Devices Market Report Segment

By Type

• Insulin Syringes
• Insulin Pens
• Insulin Jet Injectors
• Insulin Pumps

By End-User

• Hospitals & Clinics
• Homecare

Global Insulin Delivery Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/insulin-delivery-devices-market